Regulation of the NLRP3 inflammasome with natural products against chemical-induced liver injury

Pharmacol Res. 2021 Feb:164:105388. doi: 10.1016/j.phrs.2020.105388. Epub 2020 Dec 21.

Abstract

The past decades have witnessed significant progress in understanding the process of sterile inflammation, which is dependent on a cytosolic complex termed the nucleotide-binding oligomerization domain (NOD)-like receptor containing pyrin domain 3 (NLRP3) inflammasome. Activation of NLRP3 inflammasome requires two steps, including the activation of Toll-like receptor (TLR) by its ligands, resulting in transcriptional procytokine and inflammasome component activation, and the assembly and activation of NLRP3 inflammasome triggered by various danger signals, leading to caspase-1 activation, which could subsequently cleave procytokines into their active forms. Metabolic disorders, ischemia and reperfusion, viral infection and chemical insults are common pathogenic factors of liver-related diseases that usually cause tissue damage and cell death, providing numerous danger signals for the activation of NLRP3 inflammasome. Currently, natural products have attracted much attention as potential agents for the prevention and treatment of liver diseases due to their multitargets and nontoxic natures. A great number of natural products have been shown to exhibit beneficial effects on liver injury induced by various chemicals through regulating NLRP3 inflammasome pathways. In this review, the roles of the NLRP3 inflammasome in chemical-induced liver injury (CILI) and natural products that exhibit beneficial effects in CILI through the regulation of inflammasomes were systematically summarized.

Keywords: Acute liver failure; Chemical-induced liver injury; Inflammation; NLRP3 inflammasome; Natural products.

Publication types

  • Research Support, Non-U.S. Gov't
  • Systematic Review

MeSH terms

  • Animals
  • Biological Products / pharmacology
  • Biological Products / therapeutic use*
  • Chemical and Drug Induced Liver Injury, Chronic / drug therapy*
  • Chemical and Drug Induced Liver Injury, Chronic / metabolism
  • Humans
  • Inflammasomes / metabolism*
  • NLR Family, Pyrin Domain-Containing 3 Protein / metabolism*

Substances

  • Biological Products
  • Inflammasomes
  • NLR Family, Pyrin Domain-Containing 3 Protein